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The results of the AUC/ROC curve analysis are presented in the Table, A. Determination of blood eosinophils followed by FeNO had the highest AUROC (best predictive capacity of eosinophils in sputum), although the differences were not significantly different. When both parameters were associated, the predictive capacity improved discretely, but again not significantly. On the contrary, ECP had a very poor predictive capacity. The multivariate logistic regression model showed that eosinophils in blood were significantly associated with sputum eosinophilia ≥3% (OR, 1.01; P=.022) and, albeit marginally, with FeNO (OR, 1.04; P=.052). A cut-off point for eosinophils in blood ≥200 mm 3 had high sensitivity, but low sensitivity, for both treated and untreated patients ( Table, B ). When combined with determination of FeNO, blood eosinophilia significantly improves specificity, especially in patients not treated with corticosteroids. Treatment with inhaled corticosteroids worsened the predictive capacity, especially of FeNO. Blood eosinophils combined with FeNO showed a negative predictive value of 67%. Our data allow us to conclude that 40% of patients would be misclassified, if blood eosinophils alone or in combination with FeNO are used The relationship between eosinophils in blood and sputum is controversial, with contradictory data in children [5] and adults [6] , especially in populations with more severe asthma than the present one. However, Zahng et al [7] reported that blood eosinophils were highly predictive of eosinophilic asthma, at a blood eosinophil cut-off of 260/mm 3 . In a population with mild or moderate asthma whose results were replicated in an external validation cohort of severe asthmatics, Wagener et al [8] reported similar results and suggested, as do we, that FeNO did not demonstrate a clear added value to the blood eosinophil count. Finally, in a recent survey, Demarche et al [9] were able to correctly classify asthma as eosinophilic or noneosinophilic in only 58% of patients from a cohort of 869 patients using a combination of FeNO, blood eosinophils, and serum total IgE as a surrogate marker. To our knowledge, no previous studies have directly assessed the influence of inhaled corticosteroids, because almost all the populations studied had large numbers of patients treated with them. This therapy rapidly decreases FeNO levels and to a greater extent than sputum or blood eosinophils. Blood eosinophils transmigrate quickly into lung tissue and the airways, with the result that the association between them and airway inflammation might be transient. Fully activated eosinophils are located outside the bloodstream, and the real significance of serum ECP is not well known, thus possibly explaining why it fails as a good surrogate marker of eosinophilia in sputum. Furthermore, local eosinophilopoiesis, which could eliminate the generally closer relationship between blood and sputum eosinophils, is present in cases of severe eosinophilic asthma, although it may also be observed in milder forms of the disease [10]. Our study is limited by the fact that we did not replicate our findings in an external validation cohort. Nevertheless, splitting our
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Influence of Treatment With Inhaled Corticosteroids
Bronchial asthma is a heterogeneous disease that includes various phenotypes with differences in clinical expression and response to therapy. Among the various inflammatory phenotypes, eosinophilic asthma is associated with a good response to inhaled corticosteroids and a benefit from new specific biologics such as omalizumab or IL-5 antagonists. In addition, high eosinophilia is associated with an increased risk of exacerbations [1] . Eosinophilic asthma is usually defined as that presenting eosinophil levels greater than 3% in sputum samples. However, the several well-known limitations of sputum analysis mean that the technique is only available in highly specialized centers [2] .
In a previous study of 124 nonsmokers with mild or moderate persistent asthma, we showed that the fraction of exhaled nitric oxide (FeNO), an easily obtained inflammatory marker, was highly sensitive for detecting eosinophilic asthma in patients who did not receive treatment with corticosteroids [3] . In the same cohort, we assessed the predictive capacity of another inflammatory marker that is also accessible in routine clinical practice, namely, eosinophil cationic protein (ECP), a marker of activation of eosinophils, alone or combined with FeNO measurements. We also assessed the influence of corticosteroid treatment on this predictive capacity. The methodology used has been described in detail elsewhere [3] , namely, a cross-sectional study with data collected at a single visit. Induced sputum was analyzed according to the methodology of Fahy et al [4] .
Peripheral blood eosinophil counts were obtained from standard complete blood counts, ECP was measured using the standard kit ImmunoCAP ECP (Thermo Fisher Scientific), and FeNO was assessed using an online device at a constant flow of 50 mL/s (Niox Mino; Aerocrine AB). Receiver operating curves (ROC) were constructed to assess the discriminative ability of FeNO, ECP, and blood eosinophils to classify eosinophilic asthma (eosinophils in sputum ≥3%). The sample would have precluded studying the effect of inhaled corticosteroids on these surrogate markers.
In conclusion, blood eosinophilia has good sensitivity but lower specificity for detection of eosinophilia in sputum, even in patients treated with inhaled corticosteroids, in contrast with FeNO, whose sensitivity decreases in patients treated with corticosteroids. Serum ECP seems useless as a surrogate marker of sputum eosinophilia. In treated patients, the balance between specificity and sensitivity improves only discretely when blood eosinophil counts are associated with FeNO measurements. Although these surrogate markers have clinical value, they cannot substitute induced sputum cytology.
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Epidemiological Study of the Allergic Population in the North of Gran Canaria
Palabras clave: Perfil de sensibilización. Enfermedades alérgicas. Asma. Rinitis. Ácaros de polvo doméstico.
The prevalence of allergic diseases has increased considerably around the world during the last few decades. Although many factors contribute to this increase, climate change is one of the most important [1] . Gran Canaria is a volcanic island located off the western coast of North Africa. It is close to the Sahara Desert-a major source of natural mineral particles-and is impacted by Saharan dust for around 30% of the year [2] . The weather on the island is hot and humid, resulting in a high prevalence of allergic asthma [3] . Reliable data on other allergic conditions are scarce. Likewise, the sensitization profile of patients from the Canary Islands has never been compared with that of patients from other parts of Spain.
We conducted a descriptive, retrospective study from January 2010 through December 2012. The study population comprised all patients over the age of 14 attended at 1 of the 6 outpatient clinics of the Allergy Department at Hospital Universitario de Gran Canaria Doctor Negrín and who agreed to participate in the study. According to the latest government statistics, the Canary Islands have 2 118 519 inhabitants, of whom 845 676 live on Gran Canaria Island (40%). Our hospital is the core health center for the north of Gran Canaria, covering the needs of 336 000 people. In this study, we present demographic and clinical data and compare them with those reported in "Alergológica 2015", a multicenter descriptive and prospective study performed in Spain [4] . Patients underwent skin prick tests (SPT) with extracts of mite, animal dander, molds, latex, and pollens (ALK Abelló). A positive SPT was defined as a mean wheal diameter of at least 3 mm [5]. Total
